Neuraly, a TEDCO MII and MVF portfolio company, launches with $36M funding round
Source: External source
The Maryland biotech startup is developing new treatments for Parkinson’s disease and Alzheimer’s disease.
Posted July 20, 2018
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com